Development of Autoimmune Hypothyroidism after Interferon-beta 1a Treatment in Patient with Multiple Sclerosis: A Case Report

Authors

  • Md Abdul Awal Institute of Nuclear Medicine and Allied sciences, Bogra
  • Md Sunny Anam Chowdhury Institute of Nuclear Medicine and Allied sciences, Bogra
  • Md Hafizur Rahman Institute of Nuclear Medicine and Allied Sciences, Faridpur

DOI:

https://doi.org/10.3329/bjnm.v19i2.36014

Keywords:

Interferon-β 1a, Multiple sclerosis, Autoimmune hypothyroidism

Abstract

Interferon beta therapy is a well-established treatment of patients suffering from multiple sclerosis, a demyelinating disease of the central nervous system. Since type I interferons have immunomodulatory properties, these cytokines may trigger several autoimmune disorders. In this case, we report the development of autoimmune hypothyroidism in a multiple sclerosis patients receiving interferon-β 1a.

Bangladesh J. Nuclear Med. 19(2): 149-151, July 2016

Downloads

Download data is not yet available.
Abstract
8
PDF
17

Downloads

Published

2018-03-19

How to Cite

Awal, M. A., Chowdhury, M. S. A., & Rahman, M. H. (2018). Development of Autoimmune Hypothyroidism after Interferon-beta 1a Treatment in Patient with Multiple Sclerosis: A Case Report. Bangladesh Journal of Nuclear Medicine, 19(2), 149–151. https://doi.org/10.3329/bjnm.v19i2.36014

Issue

Vol. 19 No. 2 (2016)

Section

Case Reports

License

All rights reserved to Editor-in-Chief, Bangladesh Journal of Nuclear Medicine, Society of Nuclear Medicine, Bangladesh